| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.36 | 7e-24 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-05 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.2 | 6e-05 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0002 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0006 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.17 | 0.0007 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0008 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0008 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |